Literature DB >> 22157400

Diagnosis of growth hormone deficiency in childhood.

Takara Stanley1.   

Abstract

PURPOSE OF REVIEW: The diagnosis of growth hormone deficiency (GHD) in childhood is challenging, in large part because of the lack of a true gold standard and the relatively poor performance of available diagnostic testing. This review discusses the recent literature on this topic. RECENT
FINDINGS: Auxology and clinical judgment remain the foundation for the diagnosis of GHD. Provocative growth hormone testing is poorly reproducible, dependent on factors such as body composition and pubertal status, and further limited by significant variability among commercially available growth hormone assays. Measurement of insulin-like growth factor I and insulin-like growth factor-binding protein 3 is not diagnostically useful in isolation but is helpful in combination with other diagnostic measures. Neuroimaging is also useful to inform diagnosis, as pituitary abnormalities suggest a higher likelihood of GHD persisting into adulthood. Although genetic testing is not routinely performed in the diagnosis of GHD at the present time, multiple recent reports raise the possibility that it may play a more important role in diagnosing GHD in the future.
SUMMARY: Beyond physicians' integrated assessment of auxology, clinical presentation, and bone age, current tools to diagnose GHD are suboptimal. Recent literature emphasizes the need to reappraise our current practice and to consider new tools for diagnosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22157400      PMCID: PMC3279941          DOI: 10.1097/MED.0b013e32834ec952

Source DB:  PubMed          Journal:  Curr Opin Endocrinol Diabetes Obes        ISSN: 1752-296X            Impact factor:   3.243


  46 in total

1.  Expanding the spectrum of mutations in GH1 and GHRHR: genetic screening in a large cohort of patients with congenital isolated growth hormone deficiency.

Authors:  Kyriaki S Alatzoglou; James P Turton; Daniel Kelberman; Peter E Clayton; Ameeta Mehta; Charles Buchanan; Simon Aylwin; Elisabeth C Crowne; Henrik T Christesen; Niels T Hertel; Peter J Trainer; Martin O Savage; Jamal Raza; Kausik Banerjee; Sunil K Sinha; Svetlana Ten; Talat Mushtaq; Raja Brauner; Timothy D Cheetham; Peter C Hindmarsh; Primus E Mullis; Mehul T Dattani
Journal:  J Clin Endocrinol Metab       Date:  2009-06-30       Impact factor: 5.958

Review 2.  Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited.

Authors:  R G Rosenfeld; K Albertsson-Wikland; F Cassorla; S D Frasier; Y Hasegawa; R L Hintz; S Lafranchi; B Lippe; L Loriaux; S Melmed
Journal:  J Clin Endocrinol Metab       Date:  1995-05       Impact factor: 5.958

3.  Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.

Authors:  A Juul; K W Kastrup; S A Pedersen; N E Skakkebaek
Journal:  J Clin Endocrinol Metab       Date:  1997-04       Impact factor: 5.958

4.  Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children.

Authors:  E Ghigo; J Bellone; G Aimaretti; S Bellone; S Loche; M Cappa; E Bartolotta; F Dammacco; F Camanni
Journal:  J Clin Endocrinol Metab       Date:  1996-09       Impact factor: 5.958

5.  Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults.

Authors:  M Maghnie; C Strigazzi; C Tinelli; M Autelli; M Cisternino; S Loche; F Severi
Journal:  J Clin Endocrinol Metab       Date:  1999-04       Impact factor: 5.958

6.  Within-subject variability and analytic imprecision of insulinlike growth factor axis and collagen markers: implications for clinical diagnosis and doping tests.

Authors:  Tuan V Nguyen; Anne E Nelson; Christopher J Howe; Markus J Seibel; Robert C Baxter; David J Handelsman; Ray Kazlauskas; Ken K Ho
Journal:  Clin Chem       Date:  2008-06-20       Impact factor: 8.327

7.  The -202 A allele of insulin-like growth factor binding protein-3 (IGFBP3) promoter polymorphism is associated with higher IGFBP-3 serum levels and better growth response to growth hormone treatment in patients with severe growth hormone deficiency.

Authors:  Everlayny Fiorot Costalonga; Sonir R Antonini; Gil Guerra-Junior; Berenice Bilharinho Mendonca; Ivo J P Arnhold; Alexander A L Jorge
Journal:  J Clin Endocrinol Metab       Date:  2008-11-04       Impact factor: 5.958

Review 8.  Growth hormone deficiency in children.

Authors:  Erick J Richmond; Alan D Rogol
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

9.  Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature.

Authors:  Jacques Pantel; Marie Legendre; Sylvie Cabrol; Latifa Hilal; Yassir Hajaji; Séverine Morisset; Sylvie Nivot; Marie-Pierre Vie-Luton; Dominique Grouselle; Marc de Kerdanet; Abdelkrim Kadiri; Jacques Epelbaum; Yves Le Bouc; Serge Amselem
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

10.  Do all patients with childhood-onset growth hormone deficiency (GHD) and ectopic neurohypophysis have persistent GHD in adulthood?

Authors:  Juliane Léger; Stéphanie Danner; Dominique Simon; Catherine Garel; Paul Czernichow
Journal:  J Clin Endocrinol Metab       Date:  2004-11-16       Impact factor: 5.958

View more
  27 in total

Review 1.  The effects of dietary protein and amino acids on skeletal metabolism.

Authors:  Jessica D Bihuniak; Karl L Insogna
Journal:  Mol Cell Endocrinol       Date:  2015-04-02       Impact factor: 4.102

2.  First-year predictors of health-related quality of life changes in short-statured children treated with human growth hormone.

Authors:  J Quitmann; J Bloemeke; H-G Dörr; M Bullinger; S Witt; N Silva
Journal:  J Endocrinol Invest       Date:  2019-03-06       Impact factor: 4.256

3.  Clonidine and glucagon stimulation for testing growth hormone secretion in children and adolescents: can we make it with fewer samples?

Authors:  A Christoforidis; P Triantafyllou; A Slavakis; G Katzos
Journal:  J Endocrinol Invest       Date:  2013-07-23       Impact factor: 4.256

4.  Growth failure in focal dermal hypoplasia.

Authors:  Stephanie C Hsu; Sarah Bartz; Laura Pyle; Mary Fete; Shanlee Davis; Rebecca Ohman-Hanson; Timothy J Fete; Kathleen J Motil
Journal:  Am J Med Genet A       Date:  2019-01-28       Impact factor: 2.802

5.  Endocrine Deficiency As a Function of Radiation Dose to the Hypothalamus and Pituitary in Pediatric and Young Adult Patients With Brain Tumors.

Authors:  Ralph E Vatner; Andrzej Niemierko; Madhusmita Misra; Elizabeth A Weyman; Claire P Goebel; David H Ebb; Robin M Jones; Mary S Huang; Anita Mahajan; David R Grosshans; Arnold C Paulino; Takara Stanley; Shannon M MacDonald; Nancy J Tarbell; Torunn I Yock
Journal:  J Clin Oncol       Date:  2018-08-17       Impact factor: 44.544

6.  Revaluation of the clinical and metabolic behavior of children with isolated growth hormone deficiency during GH treatment according to newly proposed note 39 of the Italian Medicines Agency (AIFA).

Authors:  A Ciresi; F Cicciò; M C Amato; C Giordano
Journal:  J Endocrinol Invest       Date:  2015-05-27       Impact factor: 4.256

7.  Pituitary imaging in 129 children with growth hormone deficiency: A spectrum of findings.

Authors:  Rushaid N A AlJurayyan; Nasir A M AlJurayyan; Hala G Omer; Sharifah D A Alissa; Hessah M N AlOtaibi; Reem A H AlKhalifah; Amir M I Babiker; Sarar Mohamed
Journal:  Sudan J Paediatr       Date:  2017

8.  Acute presentation of craniopharyngioma in children and adults in a Danish national cohort.

Authors:  E H Nielsen; J O Jørgensen; P Bjerre; M Andersen; C Andersen; U Feldt-Rasmussen; L Poulsgaard; L Ø Kristensen; J Astrup; J Jørgensen; P Laurberg
Journal:  Pituitary       Date:  2013-12       Impact factor: 4.107

9.  Revisiting peak serum cortisol response to insulin-induced hypoglycemia in children.

Authors:  J B Drummond; B S Soares; W Pedrosa; A Ribeiro-Oliveira
Journal:  J Endocrinol Invest       Date:  2020-09-21       Impact factor: 4.256

10.  Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serum.

Authors:  Bryan Krastins; Amol Prakash; David A Sarracino; Dobrin Nedelkov; Eric E Niederkofler; Urban A Kiernan; Randall Nelson; Maryann S Vogelsang; Gouri Vadali; Alejandra Garces; Jennifer N Sutton; Scott Peterman; Gregory Byram; Bruno Darbouret; Joëlle R Pérusse; Nabil G Seidah; Benoit Coulombe; Johan Gobom; Erik Portelius; Josef Pannee; Kaj Blennow; Vathany Kulasingam; Lewis Couchman; Caje Moniz; Mary F Lopez
Journal:  Clin Biochem       Date:  2013-01-08       Impact factor: 3.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.